2021 STAT Breakthrough Science Summit
The 2021 STAT Breakthrough Science Summit will take you inside these innovations, examining how they’re being developed, adopted, and paid for. We’ll also take a look at the breakthroughs that haven’t yet hit the market, but have the potential to redefine health and medicine in the years to come.
Session: The Future of Gene Therapy
Katherine High, M.D., president, therapeutics, AskBioBobby Gaspar, M.D., Ph.D. chief executive officer, Orchard TherapeuticsSekar Kathiresan, M.D., co-founder and chief executive officer, Verve TherapeuticsAdam Feuerstein, senior writer, biotech, STAT (moderator)
Kathy High led the development of the first gene therapy. Now she, along with several other top executives, will guide us through what’s next.
Tuesday, July 13, 2021
1:40 p.m. ET